cysteine has been researched along with acetylsalicylic acid lysinate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haggart, K; Lee, DK; Lipworth, BJ; Robb, FM | 1 |
Dal Negro, RW; Micheletto, C; Tognella, S; Trevisan, F; Visconti, M | 1 |
Borish, L; Pal, K; Payne, SC; Ramsden, M; Shim, YM; Steinke, JW | 1 |
1 trial(s) available for cysteine and acetylsalicylic acid lysinate
Article | Year |
---|---|
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
Topics: Acetates; Administration, Inhalation; Adult; Aspirin; Asthma; Confidence Intervals; Cross-Over Studies; Cyclopropanes; Cysteine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leukotrienes; Lysine; Male; Middle Aged; Nasal Provocation Tests; Peak Expiratory Flow Rate; Quinolines; Reference Values; Reproducibility of Results; Spirometry; Sulfides | 2004 |
2 other study(ies) available for cysteine and acetylsalicylic acid lysinate
Article | Year |
---|---|
Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
Topics: Adult; Aspirin; Asthma; Bronchial Hyperreactivity; Cysteine; Female; Forced Expiratory Volume; Humans; Leukotriene E4; Leukotrienes; Lysine; Male; Middle Aged; Nasal Cavity; Nasal Provocation Tests; Rhinometry, Acoustic | 2007 |
Suppression of aspirin-mediated eosinophil activation by prostaglandin E
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Cysteine; Dinoprostone; Drug Hypersensitivity; Eosinophils; Humans; Ketorolac; Leukotriene B4; Leukotrienes; Lysine; Sodium Salicylate | 2019 |